Reuters logo
7 months ago
BRIEF-Biomarin begins phase 3 trial for treatment for children with achondroplasia
December 12, 2016 / 2:03 PM / 7 months ago

BRIEF-Biomarin begins phase 3 trial for treatment for children with achondroplasia

1 Min Read

Dec 12 (Reuters) - Biomarin Pharmaceutical Inc

* Biomarin Pharmaceutical says in addition, Biomarin is planning a separate phase 2 study evaluating effect of Vosoritide in infants and toddlers

* Biomarin enrolls first participant in phase 3 trial of vosoritide for treatment of children with Achondroplasia Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below